-

Xevant Releases New eBook Uncovering the Top 4 PBM Trends Reshaping Pharmacy Benefits in 2025

AI-powered insights reveal industry shifts in drug cost management, transparency, and access for PBMs, brokers, consultants, TPAs, health plans, and employers.

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in AI-driven pharmacy benefits optimization, today announced the release of its latest eBook: Top 4 PBM Trends to Watch in 2025 and Beyond. The publication explores four critical trends that are transforming the pharmacy benefits landscape and offers timely strategies for pharmacy benefit managers, brokers, benefits consultants, health plan executives, TPAs, and self-insured employers.

The free eBook is available for download at: https://www.xevant.com/ebook/top-4-pbm-trends-to-watch-in-2025/

Key findings include:

  • The rise of transparent, technology-powered PBM models
  • The explosive growth of GLP-1 therapies and the urgent need for sustainable cost strategies
  • Accelerated adoption of biosimilars — including the upcoming launch of Stelara alternatives
  • The emergence of high-cost gene therapies and innovative payment models like outcome-based contracts and annuities

“These trends aren’t just reshaping the PBM market — they’re forcing a total rethinking of how we manage pharmacy benefits,” said Brandon Newman, CEO of Xevant. “With soaring drug prices and increased regulatory scrutiny, organizations can’t afford to rely on legacy models. This eBook delivers a practical, data-driven look at what’s next and how to get ahead of it.”

The report also outlines how AI is transforming pharmacy analytics, turning months of manual reporting into real-time, automated insights that detect inefficiencies, improve compliance, and reduce drug spend.

Why it matters:

As costs climb and new therapies hit the market, stakeholders across the healthcare ecosystem are under pressure to adapt. This eBook provides strategic guidance for decision-makers seeking to control pharmacy costs while ensuring access, transparency, and measurable outcomes.

Call to Action:

Download the full eBook today at: https://www.xevant.com/ebook/top-4-pbm-trends-to-watch-in-2025/

About Xevant

Xevant is a leader in real-time, AI-powered pharmacy benefits optimization. By automating complex analytics and delivering daily, actionable insights, Xevant empowers PBMs, health plans, and self-insured employers to reduce costs, improve performance, and enhance patient outcomes. With intelligent automation and unmatched transparency, Xevant is redefining how pharmacy benefits are managed. Learn more at www.xevant.com.

Contacts

Media Contact:
Society22 PR
Rachel Moore
xevant@society22pr.com
929.367.8993

Xevant


Release Versions

Contacts

Media Contact:
Society22 PR
Rachel Moore
xevant@society22pr.com
929.367.8993

More News From Xevant

Xevant Launches VerX: A Bold Strike Against the Rx Cost Crisis

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in real-time pharmacy benefits AI and analytics, today announced the launch of VerX (pronounced “Vair-ex”), a powerful new platform that redefines how pharmacy benefits are optimized, managed, and controlled. VerX is the first platform to crack open the black box of pharmacy benefits by reverse engineering prescription claims to reveal the lowest achievable net cost for every claim, in real time. Built on over eight years of industry-leading data in...

Ivím at Work, Offered by Ivím Health and Xevant, Named Gold Stevie® Award Winner in 2025 American Business Awards®

LEHI, Utah--(BUSINESS WIRE)--Ivím at Work, a joint solution from Ivím Health and Xevant, has been named the winner of the Gold Stevie® Award in the Consumer Products category in the 23rd Annual American Business Awards®. The American Business Awards are the premier business awards program in the U.S., open to public and private, for-profit and nonprofit organizations of all sizes. Nicknamed the Stevies—from the Greek word meaning “crowned”—the awards will be presented at a gala ceremony on Tues...

Xevant Unveils 2025 Drug Price Inflation White Paper: A Data-Driven Look at Rising Pharmaceutical Costs and Future Implications

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leading provider of real-time data analytics for pharmacy benefit management, today announced the release of its 2025 Drug Price Inflation White Paper, providing key insights into the ongoing surge in pharmaceutical prices and what it means for payers, employers, and pharmacy benefit managers (PBMs). As the cost of healthcare continues to escalate, the new year has brought a fresh wave of price hikes across the pharmaceutical landscape. Within the first tw...
Back to Newsroom